World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01423929
Date of registration: 25/08/2011
Primary sponsor: Region Skane
Public title: Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion SOCCER
Scientific title: Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion
Date of first enrolment: January 2012
Target sample size: 100
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01423929
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment  
Countries of recruitment
Sweden
Contacts
Name:   Mahin Akbarzadeh, MSc, RN
Address: 
Telephone: +46 46 176781
Email:
Affiliation: 
Name:   Ulf Ekelund, MD PhD
Address: 
Telephone:
Email:
Affiliation:  Skåne University Hospital at Lund
Key inclusion & exclusion criteria

Inclusion Criteria:

- STEMI patient transported with ambulance to SUS Lund or Malmö or Helsingborg
hospital, and accepted for acute PCI

- Symptom duration less than 6 hours

- Normal SaO2 (= 94 %) measured with pulse oximeter

- Informed consent

Exclusion Criteria:

- Previous AMI

- Inability to make decision to participate; dementia and the like

- For CMR: Significant claustrophobia, prostheses or other magnetic material inside the
body



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
ST Elevation Myocardial Infarction
Intervention(s)
Device: Room air
Drug: Oxygen
Primary Outcome(s)
Myocardial salvage index [Time Frame: Day 4-6 after the acute PCI]
Secondary Outcome(s)
Area at risk [Time Frame: Day 4-6 after the acute PCI]
Blood oxygen saturation change [Time Frame: From inclusion to PCI start]
Change in wall motion score index [Time Frame: From index hospitalization to 6 months]
Doses of opioids (substance and mg) and betablockers (substance and mg) [Time Frame: Given before and during the PCI]
Ejection fraction [Time Frame: Day 4-6 after the acute PCI]
Infarct size [Time Frame: Day 4-6 after the acute PCI]
Infarct size [Time Frame: First 24 h after inclusion]
Microvascular obstruction [Time Frame: Day 4-6 after the acute PCI]
Pain difference [Time Frame: At randomization vs at PCI balloon inflation start]
Perceived health [Time Frame: At 6 months]
ST segment recovery [Time Frame: 90 minutes after acute PCI]
TIMI flow [Time Frame: During acute PCI]
Use of heart failure medications (beta blockers, ACEI, ARB, diuretics, digoxin and sinus node inhibitors etc) [Time Frame: At 6 months]
Wall motion score index on echocardiography [Time Frame: Day 2-3 after acute PCI]
Secondary ID(s)
2011-001452-11
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history